Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

doi:10.1038/cdd.2008.54

Article

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

Cell death and differentiation - 1 Jun 2008

Zhou X-D, Agazie Y M

Abstract excerpt

The Src homology phosphotyrosyl phosphatase 2 (SHP2) is an essential transducer of mitogenic and cell survival signaling in the epidermal growth factor receptor (EGFR) signaling pathway. However, the role of SHP2 in aberrant EGFR and human EGFR2 (HER2) signaling and cancer, particularly in breast cancer, has not been investigated. Here, we report that SHP2 is required for mitogenic and cell survival signaling and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

Abstract excerpt

Topics

Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

Abstract excerpt

Topics

Related research